Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Zhe Lin

Showing results (341-350 of 352) with videos related to

Pageof 36
Sort By:
Redox Biology|March 25, 2022
Hsp90 S-nitrosylation at Cys521, as a conformational switch, modulates cycling of Hsp90-AHA1-CDC37 chaperone machine to aggravate atherosclerosisShuang Zhao, Xin Tang, Zian Miao, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 30, 2008
Specific EGFR mutations predict treatment outcome of stage IIIB/IV patients with chemotherapy-naive non-small-cell lung cancer receiving first-line gefitinib monotherapyChih-Hsin Yang, Chong-Jen Yu, Jin-Yuan Shih, et al.
Scientific Reports|July 13, 2016
Corrigendum: Somatic Mutations and Genetic Variants of NOTCH1 in Head and Neck Squamous Cell Carcinoma Occurrence and DevelopmentYu-Fan Liu, Shang-Lun Chiang, Chien-Yu Lin, et al.
Circulation|January 7, 2020
SNO-MLP (S-Nitrosylation of Muscle LIM Protein) Facilitates Myocardial Hypertrophy Through TLR3 (Toll-Like Receptor 3)-Mediated RIP3 (Receptor-Interacting Protein Kinase 3) and NLRP3 (NOD-Like Receptor Pyrin Domain Containing 3) Inflammasome ActivationXin Tang, Lihong Pan, Shuang Zhao, et al.
Therapeutic Advances in Medical Oncology|December 20, 2019
A phase II study of the efficacy and safety of the MET inhibitor capmatinib (INC280) in patients with advanced hepatocellular carcinomaShukui Qin, Stephen Lam Chan, Wattana Sukeepaisarnjaroen, et al.
Biomaterials|August 23, 2025
A multifunctional hydrogel promotes diabetic wound healing by remodeling iron balance and energy metabolismChen Jin, Yu-Zhe Lin, Ri-Yan Zhang, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|May 4, 2026
Measuring "third places": Comparing neighborhood data for cognitive health researchJessica M Finlay, David Rigby, Amber DeJohn, et al.
Journal of Hepatocellular Carcinoma|August 2, 2021
An Exploratory Study for the Association of Gut Microbiome with Efficacy of Immune Checkpoint Inhibitor in Patients with Hepatocellular CarcinomaYing-Chun Shen, Pei-Chang Lee, Yu-Lun Kuo, et al.
Cell Reports|August 25, 2021
Evading immune surveillance via tyrosine phosphorylation of nuclear PCNAYuan-Liang Wang, Chuan-Chun Lee, Yi-Chun Shen, et al.
Lung Cancer (Amsterdam, Netherlands)|April 22, 2008
High efficacy of erlotinib in Taiwanese NSCLC patients in an expanded access program study previously treated with chemotherapyReury-Perng Perng, Chih-Hsin Yang, Yuh-Min Chen, et al.
Pageof 36

Showing results (341-350 of 352) with videos related to

Sort By:
Pageof 36
Redox Biology|March 25, 2022
Hsp90 S-nitrosylation at Cys521, as a conformational switch, modulates cycling of Hsp90-AHA1-CDC37 chaperone machine to aggravate atherosclerosisShuang Zhao, Xin Tang, Zian Miao, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 30, 2008
Specific EGFR mutations predict treatment outcome of stage IIIB/IV patients with chemotherapy-naive non-small-cell lung cancer receiving first-line gefitinib monotherapyChih-Hsin Yang, Chong-Jen Yu, Jin-Yuan Shih, et al.
Scientific Reports|July 13, 2016
Corrigendum: Somatic Mutations and Genetic Variants of NOTCH1 in Head and Neck Squamous Cell Carcinoma Occurrence and DevelopmentYu-Fan Liu, Shang-Lun Chiang, Chien-Yu Lin, et al.
Circulation|January 7, 2020
SNO-MLP (S-Nitrosylation of Muscle LIM Protein) Facilitates Myocardial Hypertrophy Through TLR3 (Toll-Like Receptor 3)-Mediated RIP3 (Receptor-Interacting Protein Kinase 3) and NLRP3 (NOD-Like Receptor Pyrin Domain Containing 3) Inflammasome ActivationXin Tang, Lihong Pan, Shuang Zhao, et al.
Therapeutic Advances in Medical Oncology|December 20, 2019
A phase II study of the efficacy and safety of the MET inhibitor capmatinib (INC280) in patients with advanced hepatocellular carcinomaShukui Qin, Stephen Lam Chan, Wattana Sukeepaisarnjaroen, et al.
Biomaterials|August 23, 2025
A multifunctional hydrogel promotes diabetic wound healing by remodeling iron balance and energy metabolismChen Jin, Yu-Zhe Lin, Ri-Yan Zhang, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|May 4, 2026
Measuring "third places": Comparing neighborhood data for cognitive health researchJessica M Finlay, David Rigby, Amber DeJohn, et al.
Journal of Hepatocellular Carcinoma|August 2, 2021
An Exploratory Study for the Association of Gut Microbiome with Efficacy of Immune Checkpoint Inhibitor in Patients with Hepatocellular CarcinomaYing-Chun Shen, Pei-Chang Lee, Yu-Lun Kuo, et al.
Cell Reports|August 25, 2021
Evading immune surveillance via tyrosine phosphorylation of nuclear PCNAYuan-Liang Wang, Chuan-Chun Lee, Yi-Chun Shen, et al.
Lung Cancer (Amsterdam, Netherlands)|April 22, 2008
High efficacy of erlotinib in Taiwanese NSCLC patients in an expanded access program study previously treated with chemotherapyReury-Perng Perng, Chih-Hsin Yang, Yuh-Min Chen, et al.
Pageof 36